The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long been part of everyday clinical practice.
Sandoz completes $170M buy of Lucentis biosimilar from Coherus BioSciences
Sandoz’s $170 million cash deal to buy ophthalmology biosimilar Cimerli from Coherus BioSciences has completed early following its announcement in January. The deal, which is